Institute

Back to overview
Name

Universitätsinstitut für Immunologie Universität Bern

Address Universitätsinstitut für Immunologie Universität Bern
Sahlihaus 2
3010
CH-Bern
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Use of epitope-antibody constructs to target T cell epitopes in- to cells
Pichler Werner Joseph University of Berne - BE 01.10.1990 30.09.1992 Project funding (Div. I-III)

Physiologic means for selective stimulation and prolifera- tion of human T lymphocyte subsets
Pichler Werner Joseph University of Berne - BE 01.10.1987 30.09.1989 Project funding (Div. I-III)

Lymphozytenrezeptoren und genetische Veränderungen beim menschlichen Altern
de Weck Alain University of Berne - BE 01.04.1985 31.03.1987 Project funding (Div. I-III)

Towards in vivo IgE regulation
Stadler Beda Martin University of Berne - BE 01.04.1998 31.03.2003 Project funding (Div. I-III)

Human anti-IgE autoantibodies
Stadler Beda Martin University of Berne - BE 01.10.1990 31.03.1993 Project funding (Div. I-III)

Human anti-IgE antibodies
Stadler Beda Martin University of Berne - BE 01.10.1988 30.09.1990 Project funding (Div. I-III)

Synthesis and Evaluation of Peptide Derivatives of Allergological and Immunological Significance
Schneider Conrad University of Berne - BE 01.04.1992 31.03.1995 Project funding (Div. I-III)

Synthesis and Evaluation of Peptide Derivatives of Allergological and Immunological Significance
Schneider Conrad University of Berne - BE 01.04.1987 31.03.1989 Project funding (Div. I-III)

Role of human basophils and Interleukin-3 in TH2-type immune responses and allergic inflammation
Dahinden Clemens University of Berne - BE 01.10.2009 31.03.2013 Project funding (Div. I-III)

Gene targeting to the tumor vasculature by synthetic peptide ligands
Stadler Beda Martin University of Berne - BE 01.04.1996 30.09.2001 NRP 37 Somatic Gene Therapy

Charakterisierung immunbiologischer Faktoren und ihre Anwendung in der Immunologie
de Weck Alain University of Berne - BE 01.10.1981 31.03.1984 Project funding (Div. I-III)

The human basophil as a target of anti-allergic therapies
Dahinden Clemens University of Berne - BE 01.10.2001 30.09.2004 Project funding (Div. I-III)

Cellular and molecular mechanisms of immunoregulation
Bonnard Guy D. University of Berne - BE 01.04.1982 31.03.1984 Project funding (Div. I-III)

Synthesis and Evaluation of Amino Acid and Peptide Derivatives of Allergological Significance
Schneider Conrad University of Berne - BE 01.04.1981 31.03.1984 Project funding (Div. I-III)

Molecular characterisation of anti-FcepsilonRIalpha antibodies and their pathophysiological role in the immune network
Miescher Sylvia University of Berne - BE 01.04.1999 31.01.2003 Project funding (Div. I-III)

Understanding the role of antibody affinities in the regulation of allergic responses?
Bachmann Martin University of Berne - BE 01.04.2019 31.03.2023 Project funding (Div. I-III)

Apoptosis due to T cell presentation: A clue to the loss of CD4 T cells during infection?
Pichler Werner Joseph University of Berne - BE 01.09.1992 31.08.1994 Project funding (special)

Zelluläre Immunabwehr bei Krebspatienten
de Weck Alain University of Berne - BE 01.10.1975 30.09.1977 Project funding (Div. I-III)

Human basophils as effector cells and targets in allergic inflammation
Dahinden Clemens University of Berne - BE 01.10.2004 31.03.2007 Project funding (Div. I-III)

Functional analysis of CD4+ T cell response in selected HIV-in- fected subjects treated with potent antiretroviral therapy
Pichler Werner Joseph University of Berne - BE 01.04.1997 31.03.2000 Project funding (special)

Synthesis and Evaluation of Peptide Derivatives of Allergological and Immunological Significance
Schneider Conrad University of Berne - BE 01.04.1989 31.03.1992 Project funding (Div. I-III)

Analysis of mediators and cellular interactions between human mononuclear cells and neutrophils
Dahinden Clemens University of Berne - BE 01.04.1986 31.03.1988 Project funding (Div. I-III)

Synthesis and evaluation of peptide derivatives of allergologicaland immunological significance
Schneider Conrad University of Berne - BE 01.04.1995 31.03.1996 Project funding (Div. I-III)

Biological role of anti-IgE autoantibodies
Stadler Beda Martin University of Berne - BE 01.04.1993 31.03.1995 Project funding (Div. I-III)

Biology and Biochemistry of the human Mast Cell Growth Factor
Stadler Beda Martin University of Berne - BE 01.04.1986 31.03.1989 Project funding (Div. I-III)

Characterisation of T cells in human skin derived lymph. (S C O R E B)
Yawalkar Nikhil University of Berne - BE 01.07.1997 31.10.2000 Ambizione

Zelluläre Immunabwehr und Lymphokine bei Krebspatienten
de Weck Alain University of Berne - BE 01.10.1979 30.09.1982 Project funding (Div. I-III)

T cells as antigen presenting cells: Involvement in anticlono- typic regulation and tolerance induction
Pichler Werner Joseph University of Berne - BE 01.10.1994 30.09.1997 Project funding (Div. I-III)

Biological and biochemical characterization of the human basophil promoting factor
Stadler Beda Martin University of Berne - BE 01.04.1984 31.03.1986 Project funding (Div. I-III)

Basidiospore Allergy (unrecognized aeroallergens)
Helbling Arthur University of Berne - BE 01.10.1994 30.09.1996 Project funding (Div. I-III)

Beitrag im Rahmen des MD/PhD-Programmes
Fernández Polch Paula Carolina University of Berne - BE 01.10.1995 30.11.1998 MD-PhD fellowships (funded by SNSF)

Synthesis and Evaluation of Peptide Derivatives of Allergological and Immunological Significance
Schneider Conrad University of Berne - BE 01.04.1984 31.03.1987 Project funding (Div. I-III)

Basidiomycete Allergens.
Helbling Arthur University of Berne - BE 01.10.1996 31.03.1999 Project funding (Div. I-III)

Analysis of gene expression in human immuno-competent cells during senescence
de Weck Alain University of Berne - BE 01.04.1989 30.06.1991 Project funding (Div. I-III)

Unraveling the role of CD23 in the context of allergy
Vogel Monique University of Berne - BE 01.04.2018 31.03.2022 Project funding (Div. I-III)

Evaluation of autoimmune processes in HTLV III/LAV infected persons
Pichler Werner Joseph University of Berne - BE 01.10.1986 30.09.1987 Project funding (Div. I-III)

Regulation of human IgE formation
de Weck Alain University of Berne - BE 01.04.1990 31.03.1993 Project funding (Div. I-III)

Regulation of IgE synthesis in man and development of new diagnostic methods in drug allergy
de Weck Alain University of Berne - BE 01.04.1984 31.03.1987 Project funding (Div. I-III)

Untersuchung der immunologischen Phänomene mittels chemisch definierter Substanzen
de Weck Alain University of Berne - BE 01.10.1978 30.09.1981 Project funding (Div. I-III)

Regulation of IgE synthesis in man and development of new diagnostic methods in drug allergy.
de Weck Alain University of Berne - BE 01.04.1987 31.03.1990 Project funding (Div. I-III)

Allergy and Autoimmunity
Stadler Beda Martin University of Berne - BE 01.04.2003 30.09.2006 Project funding (Div. I-III)

Human basophils as effector cells and targets in allergic inflammation
Dahinden Clemens University of Berne - BE 01.04.2007 30.09.2009 Project funding (Div. I-III)

Entwicklung der peptidsynthetischen Zwei-Phasen-Methode
Schneider Conrad University of Berne - BE 01.04.1979 31.03.1981 Project funding (Div. I-III)

Rolle von menschlichen Lymphozytenrezeptoren in der Immunfunktion
Pichler Werner Joseph University of Berne - BE 01.04.1984 31.03.1986 Project funding (Div. I-III)

Regulation of T-cell function by antigen presenting cells.
Pichler Werner Joseph University of Berne - BE 01.10.1992 30.09.1994 Project funding (Div. I-III)

"2nd International Lymphokine Workshop"
de Weck Alain University of Berne - BE 01.10.1978 30.09.1979 Scientific Conferences

The role of cellular interactions and cytokines in the regulationof effector cell function in allergy
Dahinden Clemens University of Berne - BE 01.04.1998 30.09.2001 Project funding (Div. I-III)

Novel strategies to prevent allergic hypersensitivity reactions using disruptive IgE inhibitors
Eggel Alexander University of Berne - BE 01.09.2013 31.08.2016 Ambizione

The role of cellular interactions and cytokines in the regulationof effector cell function in allergy
Dahinden Clemens University of Berne - BE 01.04.1995 31.03.1998 Project funding (Div. I-III)

Mechanisms of T cell activation
Pichler Werner Joseph University of Berne - BE 01.04.1986 30.09.1987 Project funding (Div. I-III)

Entwicklung der peptidsynthetischen Zwei-Phasen-Methode
Schneider Conrad University of Berne - BE 01.10.1976 31.03.1979 Project funding (Div. I-III)

Control of human IgE regulation
Stadler Beda Martin University of Berne - BE 01.04.1995 31.03.1998 Project funding (Div. I-III)

The influence of cellular interaction upon the release of mediators by inflammatory effector cells
Dahinden Clemens University of Berne - BE 01.04.1990 31.03.1993 Project funding (Div. I-III)

The role of cellular interactions and cytokines in the regulationof effector cell function in allergy
Dahinden Clemens University of Berne - BE 01.04.1993 31.03.1995 Project funding (Div. I-III)

Induction of cytotoxic T cells by peptide immunization
Pichler Werner Joseph University of Berne - BE 01.10.1995 30.09.1998 Project funding (special)

Zelluläre Immunabwehr und Lymphokine bei Krebspatienten
de Weck Alain University of Berne - BE 01.10.1977 30.09.1979 Project funding (Div. I-III)

Analysis of gene expression in human immuno-competent cells during senescence
de Weck Alain University of Berne - BE 01.04.1987 31.03.1989 Project funding (Div. I-III)

Functional analysis of drug reactive T cells and correlation to clinical symptoms
Pichler Werner Joseph University of Berne - BE 01.10.1997 30.09.2000 Project funding (Div. I-III)

Use of antigen-antibody constructs to activate T cells
Pichler Werner Joseph University of Berne - BE 01.10.1989 30.09.1990 Project funding (Div. I-III)
-